Enrollment in private Medicare Advantage plans grew just 3.1%, below projections from Wall Street or the government.
The bill would allow Medicare to begin negotiating with pharmaceutical companies over prices for small molecule medicines 13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback